Rezolute, Inc.
Rezolute Announces Pricing of Approximately $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Transaction led by Frazier Life Sciences with participation from new and existing funds
Company newsroom
NASDAQ:RZLT
1 releases
Transaction led by Frazier Life Sciences with participation from new and existing funds